Safety Shot (NASDAQ: SHOT), a wellness and dietary supplement company, today announced significant new findings from a recent clinical trial. Conducted at The Center for Applied Health Sciences (“CAHS”), the double-blind, randomized, placebo-controlled study evaluated the acute impact of Safety Shot, the company’s dietary supplement, on consumer’s Blood Alcohol Content (“BAC”). According to the announcement, Safety Shot proved to consistently lower breath alcohol content at all measured time points compared to placebo.

The study also found significant improvements in BAC in the area under the curve (“AUC”) and maximum concentration (Cmax) for ethanol, acetaldehyde, and aldehyde dehydrogenase levels, favoring Safety Shot. In addition, trial participants reported significantly less head discomfort, reduced fatigue, increased energy levels, improvements in concentration and reduced feelings of tiredness at multiple time points throughout the study. The announcement noted that these groundbreaking findings indicate Safety Shot’s efficacy in supporting user metabolism to reduce BAC and ultimately enhance subjective feelings of well-being and physiological responses post-alcohol consumption.

To view the full press release, visit https://ibn.fm/opFdZ

About Safety Shot Inc.

Safety Shot, a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness beverage on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Safety Shot is available for retail purchase online at www.DrinkSafetyShot.com and www.Amazon.com. The company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024. For more information about the company, visit www.SafetyShotHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT  

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN